📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. (2017)

First Author: Dawson S

Attributed to: MICA: Developing novel human antibodies targeting the OPG/TRAIL axis for the treatment of pulmonary arterial hypertension (PAH) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.pharmthera.2016.06.017

PubMed Identifier: 27373854

Publication URI: http://europepmc.org/abstract/MED/27373854

Type: Journal Article/Review

Volume: 169

Parent Publication: Pharmacology & therapeutics

ISSN: 0163-7258